Ilan Oren Roivant Sciences Ltd. (ROIV) insider trading activity

Ilan Oren is of Roivant Sciences Ltd.. Currently has a direct ownership of 118,388 shares of ROIV, which is worth approximately $2.37 Million. The most recent transaction as insider was on Oct 20, 2025, when has been sold 281 shares (Common Shares) at a price of $17.74 per share, resulting in proceeds of $4,984. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 118K

13.09% 3M change

20.98% 12M change

Total Value Held $2.37 Million

Ilan Oren Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 20 2025	SELL Payment of exercise price or tax liability	$4,984 $17.74 p/Share	281 Reduced 0.24%	118,388 Common Shares
Oct 20 2025	BUY Grant, award, or other acquisition	-	1,507 Added 1.25%	118,669 Common Shares
Sep 10 2025	SELL Other acquisition or disposition	$28,132 $13.77 p/Share	2,043 Reduced 1.71%	117,162 Common Shares
Sep 10 2025	BUY Grant, award, or other acquisition	-	14,524 Added 10.86%	119,205 Common Shares
Apr 17 2025	SELL Payment of exercise price or tax liability	$1,339 $11.65 p/Share	115 Reduced 0.11%	104,681 Common Shares
Apr 17 2025	SELL Payment of exercise price or tax liability	$649 $10.15 p/Share	64 Reduced 0.06%	102,500 Common Shares
Apr 17 2025	BUY Grant, award, or other acquisition	-	2,296 Added 2.14%	104,796 Common Shares
Apr 17 2025	BUY Grant, award, or other acquisition	-	2,635 Added 2.5%	102,564 Common Shares
Jan 23 2025	SELL Payment of exercise price or tax liability	$3,508 $11.21 p/Share	313 Reduced 0.31%	99,929 Common Shares
Jan 23 2025	BUY Grant, award, or other acquisition	-	2,386 Added 2.32%	100,242 Common Shares
Oct 21 2024	BUY Grant, award, or other acquisition	-	2,303 Added 2.3%	97,856 Common Shares
Sep 12 2024	SELL Other acquisition or disposition	$42,262 $12.12 p/Share	3,487 Reduced 3.52%	95,553 Common Shares
Sep 10 2024	BUY Grant, award, or other acquisition	-	16,406 Added 14.21%	99,040 Common Shares
Jul 23 2024	SELL Payment of exercise price or tax liability	$2,367 $11.01 p/Share	215 Reduced 0.26%	82,634 Common Shares
Jul 23 2024	BUY Grant, award, or other acquisition	-	2,440 Added 2.86%	82,849 Common Shares
Apr 24 2024	SELL Payment of exercise price or tax liability	$588 $10.9 p/Share	54 Reduced 0.07%	80,409 Common Shares
Apr 24 2024	BUY Grant, award, or other acquisition	-	2,121 Added 2.57%	80,463 Common Shares
Jan 19 2024	BUY Grant, award, or other acquisition	-	3,366 Added 4.12%	78,342 Common Shares
Oct 16 2023	BUY Grant, award, or other acquisition	-	2,269 Added 2.94%	74,976 Common Shares
Sep 18 2023	SELL Other acquisition or disposition	$97,212 $11.17 p/Share	8,703 Reduced 10.69%	72,707 Common Shares
Sep 12 2023	BUY Grant, award, or other acquisition	-	17,825 Added 17.96%	81,410 Common Shares
Jul 03 2023	BUY Grant, award, or other acquisition	-	1,472 Added 2.26%	63,585 Common Shares
Apr 03 2023	BUY Grant, award, or other acquisition	-	1,942 Added 3.03%	62,113 Common Shares
Jan 03 2023	BUY Grant, award, or other acquisition	-	2,010 Added 3.23%	60,171 Common Shares
Oct 31 2022	BUY Grant, award, or other acquisition	-	2,796 Added 4.59%	58,161 Common Shares

Ilan Oren

London, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ROIV shares.

Notify only if

Value

Insider Trading

Get notified when an Roivant Sciences Ltd. insider buys or sells ROIV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Roivant Sciences Ltd.

Track Activities on ROIV

Account